Why Is Medifast (MED) Down 7.6% Since Last Earnings Report?
Medifast reported Q2 2026 results with a narrower-than-expected loss of 28 cents per share, though revenues declined 27.6% year-over-year to $76.4 million due to a 48.7% drop in active earning coaches. However, the company showed positive momentum with a 41% increase in average revenue per active coach and raised its full-year earnings guidance. Management expects a return to profitability in Q4 2026.